UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception

Alzheimer's & dementia, 2012-02, Vol.8 (1), p.S1-S68

2012

Volltextzugriff (PDF)

The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

Alzheimer's & dementia, 2013-09, Vol.9 (5), p.e111-e194

2013

Volltextzugriff (PDF)

The Role of Phosphodiesterases in Schizophrenia: Therapeutic Implications

CNS drugs, 2008, Vol.22 (12), p.983-993

Siuciak, Judith A.

2008

Volltextzugriff (PDF)

Inhibition of the striatum-enriched phosphodiesterase PDE10A: A novel approach to the treatment of psychosis

Neuropharmacology, 2006-08, Vol.51 (2), p.386-396

2006

Volltextzugriff (PDF)

Progress on Developing Endpoints for Registrational Clinical Trials of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections: Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health

Clinical infectious diseases, 2012-10, Vol.55 (8), p.1114-1121

2012

Volltextzugriff (PDF)

Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme

Psychopharmacologia, 2008-03, Vol.197 (1), p.115-126

2008

Volltextzugriff (PDF)

Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: Evidence for altered striatal function

Neuropharmacology, 2006-08, Vol.51 (2), p.374-385

2006

Volltextzugriff (PDF)

Soluble BACE-1 Activity and sAβPPβ Concentrations in Alzheimer's Disease and Age-Matched Healthy Control Cerebrospinal Fluid from the Alzheimer's Disease Neuroimaging Initiative-1 Baseline Cohort

Journal of Alzheimer's disease, 2015-01, Vol.46 (2), p.431

2015

Volltextzugriff (PDF)

CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity

Neuropharmacology, 2007-02, Vol.52 (2), p.279-290

2007

Volltextzugriff (PDF)

Antipsychotic profile of rolipram : efficacy in rats and reduced sensitivity in mice deficient in the phosphodiesterase-4b (PDE4B) enzyme

Psychopharmacologia, 2007-06, Vol.192 (3), p.415-424

2007

Volltextzugriff (PDF)

Design and Synthesis of a New Series of 4‑Heteroarylamino-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure–Activity Relationship

Journal of medicinal chemistry, 2016-12, Vol.59 (24), p.11171-11181

2016

Volltextzugriff (PDF)

Antidepressant-Like Effect of Brain-derived Neurotrophic Factor (BDNF)

Pharmacology, biochemistry and behavior, 1997-01, Vol.56 (1), p.131-137

1997

Volltextzugriff (PDF)

The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors

Psychopharmacologia, 2004-09, Vol.175 (2), p.163-169

2004

Volltextzugriff (PDF)

Performance of Heterozygous Brain-Derived Neurotrophic Factor Knockout Mice on Behavioral Analogues of Anxiety, Nociception, and Depression

Behavioral neuroscience, 2001-10, Vol.115 (5), p.1145-1153

2001

Volltextzugriff (PDF)

Behavioral characterization of mice deficient in the phosphodiesterase-10A (PDE10A) enzyme on a C57/Bl6N congenic background

Neuropharmacology, 2008-02, Vol.54 (2), p.417-427

2008

Volltextzugriff (PDF)

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease

Archives of neurology (Chicago), 2012-10, Vol.69 (10), p.1310

2012

Volltextzugriff (PDF)

1-[(1-Methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 Positive Allosteric Modulators for the Treatment of Psychosis

Journal of medicinal chemistry, 2011-03, Vol.54 (6), p.1724-1739

2011

Volltextzugriff (PDF)

Disruption of the neurokinin-3 receptor (NK3) in mice leads to cognitive deficits

Psychopharmacologia, 2007-10, Vol.194 (2), p.185-195

2007

Volltextzugriff (PDF)

In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease

Brain (London, England : 1878), 2013-07, Vol.136 (Pt 7), p.2228-2238

2013

Volltextzugriff (PDF)

3-Benzyl-1,3-oxazolidin-2-ones as mGluR2 positive allosteric modulators: Hit-to lead and lead optimization

Bioorganic & medicinal chemistry letters, 2009-05, Vol.19 (9), p.2524-2529

2009

Volltextzugriff (PDF)

Novel public-private partnerships facilitating the development and qualification of biomarkers in Alzheimer's Disease

Alzheimer's & dementia, 2011-07, Vol.7 (4), p.S329-S329

Siuciak, Judith

2011

Volltextzugriff (PDF)

P2‐068: Novel public‐private partnerships facilitating the development and qualification of biomarkers in Alzheimer's Disease

Alzheimer's & dementia, 2011-07, Vol.7 (4S_Part_10), p.S329-S329

Siuciak, Judith

2011

Volltextzugriff (PDF)

Phosphodiesterase 10A inhibitors as a novel therapeutic approach for schizophrenia

Expert opinion on drug discovery, 2007-07, Vol.2 (7), p.1001-1009

2007

Volltextzugriff (PDF)

A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation

Journal of cerebral blood flow and metabolism, 2013-01, Vol.33 (1), p.53-58

2013

Volltextzugriff (PDF)

BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration

Brain research, 1996-02, Vol.710 (1), p.11-20

1996

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Englisch
(58)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Animals
(30)
Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Biological And Medical Sciences
(23)
Neurosciences
(23)
Neurosciences & Neurology
(23)
Male
(20)
Rats
(15)
Humans
(14)
Mice
(14)
Fundamental And Applied Biological Sciences. Psychology
(12)
Medical Sciences
(12)
Neurology
(12)
Pharmacology & Pharmacy
(12)
Schizophrenia
(12)
Brain - Metabolism
(11)
Rats, Sprague-Dawley
(11)
Mice, Knockout
(10)
Motor Activity - Drug Effects
(9)
Psychology. Psychoanalysis. Psychiatry
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception

The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

The Role of Phosphodiesterases in Schizophrenia: Therapeutic Implications

Inhibition of the striatum-enriched phosphodiesterase PDE10A: A novel approach to the treatment of psychosis

Progress on Developing Endpoints for Registrational Clinical Trials of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections: Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health

Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme

Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: Evidence for altered striatal function

Soluble BACE-1 Activity and sAβPPβ Concentrations in Alzheimer's Disease and Age-Matched Healthy Control Cerebrospinal Fluid from the Alzheimer's Disease Neuroimaging Initiative-1 Baseline Cohort

CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity

Antipsychotic profile of rolipram : efficacy in rats and reduced sensitivity in mice deficient in the phosphodiesterase-4b (PDE4B) enzyme

Design and Synthesis of a New Series of 4‑Heteroarylamino-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure–Activity Relationship

Antidepressant-Like Effect of Brain-derived Neurotrophic Factor (BDNF)

The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors

Performance of Heterozygous Brain-Derived Neurotrophic Factor Knockout Mice on Behavioral Analogues of Anxiety, Nociception, and Depression

Behavioral characterization of mice deficient in the phosphodiesterase-10A (PDE10A) enzyme on a C57/Bl6N congenic background

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease

1-[(1-Methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 Positive Allosteric Modulators for the Treatment of Psychosis

Disruption of the neurokinin-3 receptor (NK3) in mice leads to cognitive deficits

In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease

3-Benzyl-1,3-oxazolidin-2-ones as mGluR2 positive allosteric modulators: Hit-to lead and lead optimization

Novel public-private partnerships facilitating the development and qualification of biomarkers in Alzheimer's Disease

P2‐068: Novel public‐private partnerships facilitating the development and qualification of biomarkers in Alzheimer's Disease

Phosphodiesterase 10A inhibitors as a novel therapeutic approach for schizophrenia

A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation

BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration

Suchergebnisse filtern